A notable advancement in diabetes management is emerging with the approval of tirzepatide in a 45mg form. This updated offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://tasneemjkpv887143.wikiconversation.com/8051020/groundbreaking_development_tirzepatide_45mg_for_glucose_regulation